10.11.23
Booth 5811
TSI Group will demonstrate the work it has been doing under its “B2B-4C” model, which relies on the company taking a more consumer-centric approach which responds more adeptly to emerging trends.
“Everything we do starts with the consumer and is delivered through our business customers,” said Joe Zhou, CEO. “We don’t wait for customers to come to us with a challenge. We’re doing the early work for them. We’re out there finding the trends and opportunities. Then, we use our global resources and decades of experience to develop the science and evidence-based formulas with the best delivery system, dosage and form the consumer loves, so we’re ready when the market is ready.”
“From day one, we’ve demonstrated our commitment to this B2B-4C model,” said Larry Kolb, president. “When we started TSI, we worked hard to make ingredients better and safer for consumers. Now, we’re focused on delivering consumer health solutions to our B2B partners by integrating our research, formulations and manufacturing capabilities. It’s really neat to see the tremendous value we are able to proactively deliver to our brand partners.”
TSI Group has become globally known for several patented ingredients, including myHMB, Hobamine, enfinity, and GlucosaGreen, as well as for its six manufacturing facilities which produce ingredinets, large-scale blends, formulations, and finished, turnkey products. It has regional sales offices covering Japan, China, Malaysia, the UK, Europe, Australia, and the U.S.
A Wide Range of Capabilities
TSI Group is integrated into all facets of product development and production, the company reports.
“A lot of times, customers think something is unavailable due to engineering difficulties,” said Zhou. “But we can make the impossible possible, and the unavailable available.”
The company’s fully-integrated, turnkey solutions leverage three of its important capabilities, namely ingredient discovery, engineering solutions, and creating effective and enjoyable dosage formats.
“Some customers come to TSI because we are strong in developing efficacious formulations or delivery forms,” said Kolb. “We can design new solutions for consumers’ pain points for any of the ingredients we work with.”
Bringing Next-Level Products to Market
In addition to showcasing its capabilities as partner at all stages of product ideation, TSI will showcase its capabilities in commercializing.
For example, the non-pill category of gummies, powders, liquids, and effervescents, has now eclipsed the pill category of supplements in sales.
“Each of those formats have their shortcomings, and consumers are starting to realize some of these problems,” said Zhou. “With our FZZR technology, we can provide a delivery form that consumers can either choose to drink, put directly into their mouths or chew like a mini tablet.”
As part of the demonstration, the company will showcase before-and-after samples of its optimized ingredients, including myHMB.
TSI Group will demonstrate the work it has been doing under its “B2B-4C” model, which relies on the company taking a more consumer-centric approach which responds more adeptly to emerging trends.
“Everything we do starts with the consumer and is delivered through our business customers,” said Joe Zhou, CEO. “We don’t wait for customers to come to us with a challenge. We’re doing the early work for them. We’re out there finding the trends and opportunities. Then, we use our global resources and decades of experience to develop the science and evidence-based formulas with the best delivery system, dosage and form the consumer loves, so we’re ready when the market is ready.”
“From day one, we’ve demonstrated our commitment to this B2B-4C model,” said Larry Kolb, president. “When we started TSI, we worked hard to make ingredients better and safer for consumers. Now, we’re focused on delivering consumer health solutions to our B2B partners by integrating our research, formulations and manufacturing capabilities. It’s really neat to see the tremendous value we are able to proactively deliver to our brand partners.”
TSI Group has become globally known for several patented ingredients, including myHMB, Hobamine, enfinity, and GlucosaGreen, as well as for its six manufacturing facilities which produce ingredinets, large-scale blends, formulations, and finished, turnkey products. It has regional sales offices covering Japan, China, Malaysia, the UK, Europe, Australia, and the U.S.
A Wide Range of Capabilities
TSI Group is integrated into all facets of product development and production, the company reports.
“A lot of times, customers think something is unavailable due to engineering difficulties,” said Zhou. “But we can make the impossible possible, and the unavailable available.”
The company’s fully-integrated, turnkey solutions leverage three of its important capabilities, namely ingredient discovery, engineering solutions, and creating effective and enjoyable dosage formats.
“Some customers come to TSI because we are strong in developing efficacious formulations or delivery forms,” said Kolb. “We can design new solutions for consumers’ pain points for any of the ingredients we work with.”
Bringing Next-Level Products to Market
In addition to showcasing its capabilities as partner at all stages of product ideation, TSI will showcase its capabilities in commercializing.
For example, the non-pill category of gummies, powders, liquids, and effervescents, has now eclipsed the pill category of supplements in sales.
“Each of those formats have their shortcomings, and consumers are starting to realize some of these problems,” said Zhou. “With our FZZR technology, we can provide a delivery form that consumers can either choose to drink, put directly into their mouths or chew like a mini tablet.”
As part of the demonstration, the company will showcase before-and-after samples of its optimized ingredients, including myHMB.
